Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Kardiologiia ; 42(10): 41-4, 2002.
Article in Russian | MEDLINE | ID: mdl-12494056

ABSTRACT

Eprosartan (600-1200 mg/day) was given for 4 weeks to 28 patients aged 32-62 years with stage II-III hypertension (WHO, 1999). Left ventricular diastolic function and cerebral blood flow were assessed by echocardiography and ultrasound dopplerography. Treatment with eprosartan was associated with improvements of impaired left ventricular diastolic function, structural and functional state of the heart, venous outflow from cerebral vessels, and restoration of unpaired autoregulation of cerebral blood flow. All these phenomena could potentially lead to normalization of cerebral tissue perfusion and stabilization of cerebral blood flow.


Subject(s)
Acrylates/pharmacology , Antihypertensive Agents/pharmacology , Cerebrovascular Circulation/drug effects , Hypertension/drug therapy , Imidazoles/pharmacology , Thiophenes , Ventricular Function, Left/drug effects , Acrylates/administration & dosage , Acrylates/therapeutic use , Adult , Antihypertensive Agents/administration & dosage , Antihypertensive Agents/therapeutic use , Carotid Artery, Internal/diagnostic imaging , Diastole/drug effects , Echocardiography , Female , Follow-Up Studies , Homeostasis , Humans , Hypertension/physiopathology , Imidazoles/administration & dosage , Imidazoles/therapeutic use , Male , Middle Aged , Models, Cardiovascular , Time Factors , Treatment Outcome , Ultrasonography, Doppler, Transcranial , Vertebral Artery/diagnostic imaging
SELECTION OF CITATIONS
SEARCH DETAIL